IRIDEX Statistics
Total Valuation
IRIDEX has a market cap or net worth of $16.16 million. The enterprise value is $15.38 million.
Important Dates
The last earnings date was Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IRIDEX has 17.19 million shares outstanding. The number of shares has increased by 2.75% in one year.
| Current Share Class | 17.19M |
| Shares Outstanding | 17.19M |
| Shares Change (YoY) | +2.75% |
| Shares Change (QoQ) | +1.29% |
| Owned by Insiders (%) | 11.18% |
| Owned by Institutions (%) | 10.67% |
| Float | 11.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| Forward PS | 1.15 |
| PB Ratio | 3.45 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 1.02.
| Current Ratio | 1.94 |
| Quick Ratio | 1.22 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -139.29% and return on invested capital (ROIC) is -22.49%.
| Return on Equity (ROE) | -139.29% |
| Return on Assets (ROA) | -6.53% |
| Return on Invested Capital (ROIC) | -22.49% |
| Return on Capital Employed (ROCE) | -19.16% |
| Revenue Per Employee | $544,591 |
| Profits Per Employee | -$54,699 |
| Employee Count | 93 |
| Asset Turnover | 1.73 |
| Inventory Turnover | 3.43 |
Taxes
In the past 12 months, IRIDEX has paid $31,000 in taxes.
| Income Tax | 31,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.17% in the last 52 weeks. The beta is 0.66, so IRIDEX's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -49.17% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.11 |
| Relative Strength Index (RSI) | 44.35 |
| Average Volume (20 Days) | 106,908 |
Short Selling Information
The latest short interest is 287,959, so 1.68% of the outstanding shares have been sold short.
| Short Interest | 287,959 |
| Short Previous Month | 275,804 |
| Short % of Shares Out | 1.68% |
| Short % of Float | 2.54% |
| Short Ratio (days to cover) | 4.99 |
Income Statement
In the last 12 months, IRIDEX had revenue of $50.65 million and -$5.09 million in losses. Loss per share was -$0.30.
| Revenue | 50.65M |
| Gross Profit | 19.34M |
| Operating Income | -3.06M |
| Pretax Income | -5.06M |
| Net Income | -5.09M |
| EBITDA | -2.82M |
| EBIT | -3.06M |
| Loss Per Share | -$0.30 |
Full Income StatementBalance Sheet
The company has $5.57 million in cash and $4.79 million in debt, giving a net cash position of $788,000 or $0.05 per share.
| Cash & Cash Equivalents | 5.57M |
| Total Debt | 4.79M |
| Net Cash | 788,000 |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 4.68M |
| Book Value Per Share | -0.08 |
| Working Capital | 11.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.94 million and capital expenditures -$46,000, giving a free cash flow of -$3.99 million.
| Operating Cash Flow | -3.94M |
| Capital Expenditures | -46,000 |
| Free Cash Flow | -3.99M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
Gross margin is 38.18%, with operating and profit margins of -6.04% and -10.04%.
| Gross Margin | 38.18% |
| Operating Margin | -6.04% |
| Pretax Margin | -9.98% |
| Profit Margin | -10.04% |
| EBITDA Margin | -5.57% |
| EBIT Margin | -6.04% |
| FCF Margin | n/a |
Dividends & Yields
IRIDEX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.75% |
| Shareholder Yield | -2.75% |
| Earnings Yield | -31.47% |
| FCF Yield | -24.67% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRIDEX has an Altman Z-Score of -2.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.07 |
| Piotroski F-Score | 3 |